Real Time Touch



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




Real Time Touch

Alios Biopharma Inc patents


Recent patent applications related to Alios Biopharma Inc. Alios Biopharma Inc is listed as an Agent/Assignee. Note: Alios Biopharma Inc may have other listings under different names/spellings. We're not affiliated with Alios Biopharma Inc, we're just tracking patents.

ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "A" | Alios Biopharma Inc-related inventors


Substituted nucleosides, nucleotides and analogs thereof

Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection, with a nucleoside, a nucleotide and an analog thereof.. ... Alios Biopharma Inc

Methods of preparing substituted nucleoside analogs

Disclosed herein are methods of preparing a nucleoside analog, which are useful in treating diseases and/or conditions such as viral infections, and intermediates thereof.. . ... Alios Biopharma Inc

Oligonucleotide targeting strategy for cccdna

The present disclosure provides oligonucleotide compositions that target the covalently closed circular (ccc) dna of hepatitis b virus (hbv). Also disclosed herein are methods for treating a subject diagnosed with, or suspected of having an hbv infection and/or an hbv-associated disorder, e.g., chronic hepatitis b infection, liver failure or cirrhosis and hepatocellular carcinoma.. ... Alios Biopharma Inc

Substituted nucleosides, nucleotides and analogs thereof

Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a picornavirus infection with one or more nucleosides, nucleotides and nucleotide analogs.. . ... Alios Biopharma Inc

Modified oligonucleotides and methods of use

Modified oligonucleotides comprising modifications at the 2′ and/or 3′ positions(s) along with methods of making and use, e.g., against hbv are disclosed.. . ... Alios Biopharma Inc

Substituted nucleosides, nucleotides and analogs thereof

. . Disclosed herein are nucleosides, nucleotides and analogs thereof, pharmaceutical compositions that include one or more of nucleosides, nucleotides and analogs thereof, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a disease and/or a condition, including an infection from a norovirus, with a nucleoside, a nucleotide and an analog thereof.. ... Alios Biopharma Inc

Antiviral compounds

Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. ... Alios Biopharma Inc

Substituted nucleosides, nucleotides and analogs thereof

Disclosed herein are nucleosides, nucleotides and nucleotide analogs, methods of synthesizing the same and methods of treating diseases and/or conditions such as a picornavirus and/or flaviviridae infection with one or more nucleosides, nucleotides and nucleotide analogs.. . ... Alios Biopharma Inc

Compounds for the treatment of paramyxovirus viral infections

Disclosed herein are new antiviral compounds, together with pharmaceutical compositions that include one or more antiviral compounds, and methods of synthesizing the same. Also disclosed herein are methods of ameliorating and/or treating a paramyxovirus viral infection with one or more small molecule compounds. ... Alios Biopharma Inc

Method of preparing aza-pyridone compounds

Disclosed herein are methods for obtaining aza-pyridone compounds, which can be useful for ameliorating and/or treating a disease and/or a condition, including an orthomyxovirus infection.. . ... Alios Biopharma Inc

Substituted nucleosides, nucleotides and analogs thereof

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a hcv infection with one or more nucleotide analogs.. . ... Alios Biopharma Inc

Substituted nucleosides, nucleotides and analogs thereof

Disclosed herein are nucleotide analogs, methods of synthesizing nucleotide analogs and methods of treating diseases and/or conditions such as a hcv infection with one or more nucleotide analogs.. . ... Alios Biopharma Inc

Cyclic nucleotide analogs

Disclosed herein are cyclic nucleotide analogs, methods of synthesizing cyclic nucleotide analogs and methods of treating diseases and/or conditions such as viral infections, cancer, and/or parasitic diseases with cyclic nucleotide analogs.. . ... Alios Biopharma Inc








ARCHIVE: New 2018 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Alios Biopharma Inc in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Alios Biopharma Inc with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###